FWGBD Supports ASH "Right to Maternal Health Care in Hematology" Policy
At this time, we would like to express our support of and share American Society of Hematology's "The Right to Maternal Health Care in Hematology" policy. #WomensHealth is our number one priority. Period. #SCOTUS#RoeOverturned #hematology #gynecology #obstetrics
Within the policy, ASH states the following, "...women with anemia, women on blood thinners to control blood clots, women with blood cancer, and women with sickle cell disease (SCD) are especially at high risk of pregnancy related complications including death. In fact, women with SCD are 10 times more likely to die in childbirth than Black women without SCD." (6,7)
It is in this light that the American Society of Hematology (ASH) makes the following statement in support of the right to maternal life and well-being:
- Maternal health can be adversely impacted by hematologic diseases and disorders
- Termination of a pregnancy is an important clinical consideration when the mother is at risk for serious health complications and/or death
- Access to evidence-based medical information and lifesaving medical options [procedures and treatments], including termination of a pregnancy, is a maternal right
You are able to read more about this policy, by clicking on the link below. We agree with ASH and others that "No woman should face legal ramifications for childbearing decisions. The right to maternal life and well-being for our members and the patients they serve, must not be denied."